GB1183403A - Antitussive Medicament with Prolonged Effect - Google Patents

Antitussive Medicament with Prolonged Effect

Info

Publication number
GB1183403A
GB1183403A GB9794/67A GB979467A GB1183403A GB 1183403 A GB1183403 A GB 1183403A GB 9794/67 A GB9794/67 A GB 9794/67A GB 979467 A GB979467 A GB 979467A GB 1183403 A GB1183403 A GB 1183403A
Authority
GB
United Kingdom
Prior art keywords
antitussive
base
weight
medicament
noscapine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB9794/67A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Publication of GB1183403A publication Critical patent/GB1183403A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9794/67A 1966-03-18 1967-03-01 Antitussive Medicament with Prolonged Effect Expired GB1183403A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR54024A FR5227M (ko) 1966-03-18 1966-03-18

Publications (1)

Publication Number Publication Date
GB1183403A true GB1183403A (en) 1970-03-04

Family

ID=8604122

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9794/67A Expired GB1183403A (en) 1966-03-18 1967-03-01 Antitussive Medicament with Prolonged Effect

Country Status (6)

Country Link
AT (1) AT279802B (ko)
BE (1) BE695604A (ko)
DK (1) DK115144B (ko)
FR (1) FR5227M (ko)
GB (1) GB1183403A (ko)
NL (1) NL6704037A (ko)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091409A1 (en) * 1982-03-12 1983-10-12 KabiVitrum AB Pharmaceutical compositions containing carrageen
EP0233932A1 (en) * 1985-08-16 1987-09-02 New York University Anticonvulsant compositions and method
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP0454044A2 (de) * 1990-04-25 1991-10-30 Hoechst Aktiengesellschaft Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff
WO1999021586A2 (en) * 1997-10-29 1999-05-06 Eurand International S.P.A. Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
FR2906687A1 (fr) * 2006-10-10 2008-04-11 Pierre Calleja Substrat pour la conservation et la distribution d'ingredients actifs pour animaux aquatiques
US7939103B2 (en) 2004-03-19 2011-05-10 Capsulution Pharma Ag Method for producing core-shell (CS) particles and microcapsules using porous templates, CS particles and microcapsules, and the use thereof
US8092836B2 (en) 1998-03-19 2012-01-10 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
AU565487B2 (en) * 1983-09-16 1987-09-17 Fisons Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091409A1 (en) * 1982-03-12 1983-10-12 KabiVitrum AB Pharmaceutical compositions containing carrageen
US4693997A (en) * 1982-03-12 1987-09-15 Kabivitrum Ab Novel pharmaceutical composition
EP0233932A1 (en) * 1985-08-16 1987-09-02 New York University Anticonvulsant compositions and method
EP0233932A4 (en) * 1985-08-16 1988-04-26 Univ New York ANTICONVULSIVE COMPOSITIONS AND METHODS RELATING thereto.
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
US5700459A (en) * 1990-04-25 1997-12-23 Hoechst Aktiengesellschaft Pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active agent
EP0454044A3 (en) * 1990-04-25 1993-01-13 Hoechst Aktiengesellschaft Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
EP0454044A2 (de) * 1990-04-25 1991-10-30 Hoechst Aktiengesellschaft Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff
WO1999021586A2 (en) * 1997-10-29 1999-05-06 Eurand International S.P.A. Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
WO1999021586A3 (en) * 1997-10-29 1999-07-08 Eurand Int Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
US6355272B1 (en) 1997-10-29 2002-03-12 Eurand International S.P.A. Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharamaceutical compositions
US8092836B2 (en) 1998-03-19 2012-01-10 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US8168226B2 (en) 1998-03-19 2012-05-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US7939103B2 (en) 2004-03-19 2011-05-10 Capsulution Pharma Ag Method for producing core-shell (CS) particles and microcapsules using porous templates, CS particles and microcapsules, and the use thereof
FR2906687A1 (fr) * 2006-10-10 2008-04-11 Pierre Calleja Substrat pour la conservation et la distribution d'ingredients actifs pour animaux aquatiques

Also Published As

Publication number Publication date
FR5227M (ko) 1967-08-14
DK115144B (da) 1969-09-08
NL6704037A (ko) 1967-09-19
BE695604A (ko) 1967-09-18
AT279802B (de) 1970-03-25

Similar Documents

Publication Publication Date Title
GB1390772A (en) Oral narcotic composition
GB1183403A (en) Antitussive Medicament with Prolonged Effect
IE771403L (en) Injection solutions
IE781163L (en) Sustained release of veterinary medicaments
GB1517480A (en) Opiate analgesic formulation with a low potential for abuse
GB1353815A (en) Analgetic composition
GB1378348A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
NL172149C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met locaal-anesthetische werking dat een dialkylamino-2',6'-butyroxylidide en/of een farmaceutisch aanvaardbaar zout daarvan bevat, alsmede de onder toepassing van deze werkwijze verkregen gevormde farmaceutische preparaten en werkwijze voor het bereiden van dialkylamino-2',6'-butyroxilididen en de farmaceutisch aanvaardbare zouten daarvan.
ES320356A1 (es) Procedimiento para la preparaciën de pastillas medicinales comestibles
US3456051A (en) Soft gelatin sheet for soft gelatin capsule
Hartmann Amitriptyline and imipramine: effects on human sleep.
IL50355A (en) N-tetrahydrofurfuryl noroxymorphone derivatives,their preparation and pharmaceutical compositions containing them
GB1453234A (en) Liquid vehicle for pharmaceutical compositions
ES358505A1 (es) Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.
IL46864A0 (en) New pyrimido(1,2-a)quinoline derivatives,their preparation and pharmaceutical compositions containing them
GB1547562A (en) Guns eg for use in the administration of drugs or medicines to animals
IL49668A0 (en) Stable solutions of ergot alkaloids,their preparation and pharmaceutical compositions comprising them
GB769517A (en) Analgesic compositions
IE34648L (en) Pharmaceutical composition containing garcinia acid
IL43927A0 (en) Lysino-calcium chloride and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
GB1300419A (en) New morphinone derivatives and their preparation
GB894609A (en) Tannates of morphine alkaloids
IL34468A0 (en) Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them
GB1352392A (en) Phenylisopropylamine derivatives
GB1356489A (en) Compositions for and method of combating coccidiosis and mareks disease in poultry

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees